Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
7.30
+0.13 (1.81%)
Aug 14, 2025, 12:01 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bausch + Lomb | 4.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bausch + Lomb Growth | 11.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Salix | 2.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Salix Growth | 5.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diversified Products | 950.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diversified Products Growth | 0.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ortho Dermatologies | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ortho Dermatologies Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Rx | 1.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Rx Growth | 1.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Solta Medical | 440.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Solta Medical Growth | 28.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Other | -2.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 5.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bausch + Lomb Segment Profit | 1.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bausch + Lomb Segment Profit Growth | 3.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -2.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 5.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Salix Segment Profit | 1.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Salix Segment Profit Growth | 5.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diversified Products Segment Profit | 626.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diversified Products Segment Profit Growth | 7.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ortho Dermatologies Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ortho Dermatologies Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Rx Segment Profit | 376.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Rx Segment Profit Growth | 8.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Solta Medical Segment Profit | 213.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Solta Medical Segment Profit Growth | 36.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|